Hot Flashes Clinical Trial
Official title:
Effect and Predictors for Hot Flush in Women Undergoing Static Stretching Exercise : A Randomized Controlled Trial
This study investigates the effect and predictors of static stretching exercise on hot flush in women after performing 4-week stretching exercises.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | June 30, 2021 |
Est. primary completion date | June 30, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Age between 20-65 years old. 2. With hot flashes. 3. No current therapies such as hormone therapy, psychotropic medications, or sleeping pills for the past 6 months. 4. With ability to follow instructions of stretching exercise. Exclusion Criteria: 1. SBP >160 mmHg or DBP >100 mmHg 2. Medical condition under investigation or unstable condition that could affect hot flashes, like thyroid disease. 3. Any medical condition limiting the ability to participate the exercise. |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Yang Ming University | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Yang Ming University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hot flush frequency | Frequency of hot flush (time/day) | pre-intervention | |
Primary | Hot flush frequency | Frequency of hot flush (time/day) | week 1 of intervention period | |
Primary | Hot flush frequency | Frequency of hot flush (time/day) | week 2 of intervention period | |
Primary | Hot flush frequency | Frequency of hot flush (time/day) | week 3 of intervention period | |
Primary | Hot flush frequency | Frequency of hot flush (time/day) | week 4 of intervention period (post-intervention) | |
Primary | Hot flush score | The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) | pre-intervention | |
Primary | Hot flush score | The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) | week 1 of intervention period | |
Primary | Hot flush score | The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) | week 2 of intervention period | |
Primary | Hot flush score | The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) | week 3 of intervention period | |
Primary | Hot flush score | The sum of mean hot flushes multiplied by severity (mild x 1, moderate x 2, severe x 3) | week 4 of intervention period (post-intervention) | |
Secondary | Standard deviation of NN intervals (SDNN) | SDNN represents total heart rate variability. (unit: ms) | pre-intervention | |
Secondary | Standard deviation of NN intervals (SDNN) | SDNN represents total heart rate variability. (unit: ms) | week 4 of intervention period (post-intervention) | |
Secondary | Absolute total power | Absolute total power represents total activity of autonomic nervous system. (unit: ms^2) | pre-intervention | |
Secondary | Absolute total power | Absolute total power represents total activity of autonomic nervous system. (unit: ms^2) | week 4 of intervention period (post-intervention) | |
Secondary | Low frequency in normalized unit (LF norm) | LF norm represents sympathetic nerve activity. | pre-intervention | |
Secondary | Low frequency in normalized unit (LF norm) | LF norm represents sympathetic nerve activity. | week 4 of intervention period (post-intervention) | |
Secondary | High frequency in normalized unit (HF norm) | HF norm represents parasympathetic nerve activity. | pre-intervention | |
Secondary | High frequency in normalized unit (HF norm) | HF norm represents parasympathetic nerve activity. | week 4 of intervention period (post-intervention) | |
Secondary | Percentage of low frequency (LF%) | LF% represents sympathetic nerve activity. | pre-intervention | |
Secondary | Percentage of low frequency (LF%) | LF% represents sympathetic nerve activity. | week 4 of intervention period (post-intervention) | |
Secondary | Percentage of high frequency (HF%) | HF% represents parasympathetic nerve activity. | pre-intervention | |
Secondary | Percentage of high frequency (HF%) | HF% represents parasympathetic nerve activity. | week 4 of intervention period (post-intervention) | |
Secondary | LF/HF ratio (L/H ratio) | L/H ratio represents autonomic nerve balance. | pre-intervention | |
Secondary | LF/HF ratio (L/H ratio) | L/H ratio represents autonomic nerve balance. | week 4 of intervention period (post-intervention) | |
Secondary | Muscle flexibility of upper extremities | Apley's scratch test (unit: cm) | pre-intervention | |
Secondary | Muscle flexibility of upper extremities | Apley's scratch test (unit: cm) | week 4 of intervention period (post-intervention) | |
Secondary | Muscle flexibility of lower extremities | Sit-and-reach test (unit: cm) | pre-intervention | |
Secondary | Muscle flexibility of lower extremities | Sit-and-reach test (unit: cm) | week 4 of intervention period (post-intervention) | |
Secondary | Vascular endothelial function | Reflective index (RI) (unit:%) | pre-intervention | |
Secondary | Vascular endothelial function | Reflective index (RI) (unit:%) | week 4 of intervention period (post-intervention) | |
Secondary | Hot Flush Related Daily Interference Scale (HFRDIS) | Hot Flush Related Daily Interference Scale (HFRDIS), minimum value : 0, maximum value : 100, higher scores mean a worse outcome | pre-intervention | |
Secondary | Hot Flush Related Daily Interference Scale (HFRDIS) | Hot Flush Related Daily Interference Scale (HFRDIS), minimum value : 0, maximum value : 100, higher scores mean a worse outcome | week 4 of intervention period (post-intervention) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04587154 -
Womens Study to Alleviate Vasomotor Symptoms
|
N/A | |
Terminated |
NCT03642119 -
Validation of an Objective Instrument to Measure Hot Flashes During Menopause
|
||
Completed |
NCT05061563 -
A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults
|
Phase 1 | |
Completed |
NCT05419908 -
Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes
|
Phase 2 | |
Completed |
NCT01281332 -
Mechanical Device for the Relief of Hot Flashes
|
Phase 2 | |
Completed |
NCT01439945 -
Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
|
Phase 2 | |
Completed |
NCT00755417 -
Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
|
Phase 3 | |
Completed |
NCT01293695 -
Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial
|
N/A | |
Completed |
NCT00599456 -
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
|
N/A | |
Completed |
NCT00256685 -
Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause
|
Phase 3 | |
Completed |
NCT00391417 -
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
|
Phase 3 | |
Terminated |
NCT00244894 -
Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer
|
N/A | |
Completed |
NCT00010712 -
Effects of Black Cohosh on Menopausal Hot Flashes
|
Phase 2 | |
Active, not recruiting |
NCT03580499 -
Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy
|
N/A | |
Recruiting |
NCT06030388 -
Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women
|
N/A | |
Recruiting |
NCT04418115 -
Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
|
N/A | |
Active, not recruiting |
NCT05086705 -
EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer
|
N/A | |
Completed |
NCT05099159 -
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)
|
Phase 3 | |
Completed |
NCT01140646 -
Evaluation of SAMe for Hot Flashes
|
Phase 2 | |
Completed |
NCT00956813 -
Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
|
Phase 3 |